Structures by: McGlone T.
Total: 12
H69Na13O100Sb2TiW18
H69Na13O100Sb2TiW18
Dalton transactions (Cambridge, England : 2003) (2010) 39, 48 11599-11604
a=12.3948(2)Å b=17.4618(3)Å c=23.1989(4)Å
α=74.019(2)° β=78.653(2)° γ=76.950(2)°
As2H80K6O106Ti6W16
As2H80K6O106Ti6W16
Dalton transactions (Cambridge, England : 2003) (2010) 39, 48 11599-11604
a=12.2625(2)Å b=12.6540(2)Å c=15.9764(3)Å
α=73.571(2)° β=76.674(2)° γ=85.793(2)°
C20H33Ag3N10O28V10
C20H33Ag3N10O28V10
Chem.Commun. (2012) 48, 359
a=12.7703(4)Å b=13.5522(4)Å c=15.8528(6)Å
α=74.740(3)° β=83.585(3)° γ=68.634(3)°
Alpha lipoicacid nicotinamide co-crystal
C8H14O2S2,C6H6N2O
CrystEngComm (2014) 16, 26 5769
a=26.292(2)Å b=5.2948(4)Å c=34.158(3)Å
α=90.00° β=90.598(4)° γ=90.00°
2-Phenoxybenzoic acid
C13H10O3
Acta Crystallographica Section E (2005) 61, 7 o2280-o2282
a=5.2736(5)Å b=7.7366(6)Å c=13.6863(10)Å
α=89.184(6)° β=83.433(6)° γ=74.640(6)°
C20H30Ag4N10O32W10
C20H30Ag4N10O32W10
Crystal Growth & Design (2011) 11, 6 2471
a=11.2492(2)Å b=11.3536(3)Å c=13.3378(8)Å
α=65.508(3)° β=81.846(6)° γ=60.791(2)°
C24H41Ag4N12O60SbW18
C24H41Ag4N12O60SbW18
Crystal Growth & Design (2011) 11, 6 2471
a=20.5131(2)Å b=20.5131(2)Å c=33.4645(5)Å
α=90.00° β=90.00° γ=120.00°
C24H36Ag4BiN12O60W18
C24H36Ag4BiN12O60W18
Crystal Growth & Design (2011) 11, 6 2471
a=20.5547(9)Å b=20.5547(9)Å c=33.1479(19)Å
α=90.00° β=90.00° γ=120.00°
C14H80BiN7O71W18
C14H80BiN7O71W18
Crystal Growth & Design (2011) 11, 6 2471
a=12.8261(6)Å b=13.0348(5)Å c=13.3700(5)Å
α=73.647(3)° β=61.499(4)° γ=89.952(3)°
C14H70N7O66SbW18
C14H70N7O66SbW18
Crystal Growth & Design (2011) 11, 6 2471
a=13.318(3)Å b=23.362(5)Å c=23.198(5)Å
α=90.00° β=95.652(9)° γ=90.00°
C86H192BiN8O60W18
C86H192BiN8O60W18
Crystal Growth & Design (2011) 11, 6 2471
a=42.0448(3)Å b=42.0448(3)Å c=15.6967(2)Å
α=90.00° β=90.00° γ=90.00°
C76H179N10O60SbW18
C76H179N10O60SbW18
Crystal Growth & Design (2011) 11, 6 2471
a=16.5543(3)Å b=20.5284(3)Å c=22.6908(3)Å
α=92.7760(10)° β=109.4300(10)° γ=108.9400(10)°